AnaptysBio Stock (NASDAQ: ANAB) stock price, news, charts, stock research, profile.
Open | $25.54 |
Close | - |
Volume / Avg. | 177.57K / 348.64K |
Day Range | 24.95 - 25.73 |
52 Wk Range | 13.36 - 27.50 |
Market Cap | $695.81M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 24.09% |
Days to Cover | 14.21 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AnaptysBio (NASDAQ:ANAB) through any online brokerage.
Other companies in AnaptysBio’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC) and Sage Therapeutics (NASDAQ:SAGE).
There is no analysis for AnaptysBio.
AnaptysBio has a consensus price target of $40.21.
The stock price for AnaptysBio (NASDAQ: ANAB) is $25.68 last updated Today at July 9, 2024 at 3:42 PM EDT.
There are no upcoming dividends for AnaptysBio.
AnaptysBio’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for AnaptysBio.
AnaptysBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.